{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:04:09Z","timestamp":1784865849961,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1170238"],"award-info":[{"award-number":["APP1170238"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1092957"],"award-info":[{"award-number":["APP1092957"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["19\/290"],"award-info":[{"award-number":["19\/290"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010398","name":"Metro South Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010230","name":"Queensland Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013331","name":"Ingham Institute for Applied Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009888","name":"International Society for Peritoneal Dialysis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020492","name":"Translational Research Institute Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019213","name":"Amgen Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019213","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007658","name":"Baxter Healthcare Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007658","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Peritoneal dialysis (PD)-related infections, such as peritonitis, exit site, and tunnel infections, substantially impair the sustainability of PD. Accordingly, PD-related infection is the top-priority research outcome for patients and caregivers. While PD nurse trainers teach patients to perform their own PD, PD training curricula are not standardized or informed by an evidentiary base and may offer a potential approach to prevent PD infections. The Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes (TEACH-PD) trial evaluates whether a standardized training curriculum for PD nurse trainers and incident PD patients based on the International Society for Peritoneal Dialysis (ISPD) guidelines reduces PD-related infections compared to usual training practices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The TEACH-PD trial is a registry-based, pragmatic, open-label, multi-center, binational, cluster-randomized controlled trial. TEACH-PD will recruit adults aged 18 years or older who have not previously undergone PD training at 42 PD treatment units (clusters) in Australia and New Zealand (ANZ) between July 2019 and June 2023. Clusters will be randomized 1:1 to standardized TEACH-PD training curriculum or usual training practice. The primary trial outcome is the time to the first occurrence of any PD-related infection (exit site infection, tunnel infection, or peritonitis). The secondary trial outcomes are the individual components of the primary outcome, infection-associated catheter removal, transfer to hemodialysis (greater than 30 days and 180 days), quality of life, hospitalization, all-cause death, a composite of transfer to hemodialysis or all-cause death, and cost-effectiveness. Participants are followed for a minimum of 12 months with a targeted average follow-up period of 2 years. Participant and outcome data are collected from the ANZ Dialysis and Transplant Registry (ANZDATA) and the New Zealand Peritoneal Dialysis (NZPD) Registry. This protocol follows the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>TEACH-PD is a registry-based, cluster-randomized pragmatic trial that aims to provide high-certainty evidence about whether an ISPD guideline-informed standardized PD training curriculum for PD nurse trainers and adult patients prevents PD-related infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov NCT03816111. Registered on 24 January 2019.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-023-07715-0","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T17:01:57Z","timestamp":1699981317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Multi-center, pragmatic, cluster-randomized, controlled trial of standardized peritoneal dialysis (PD) training versus usual care on PD-related infections (the TEACH-PD trial): trial protocol"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8911-6856","authenticated-orcid":false,"given":"Josephine S. F.","family":"Chow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Boudville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeoungjee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suetonia","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine M.","family":"Pascoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel M.","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Reidlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Stastny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Valks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Movva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charani","family":"Kiriwandeniya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Candler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor","family":"Mihala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Buisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keri-Lu","family":"Equinox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana E.","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trudi","family":"Fuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Jaure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Jose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana S.","family":"Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-anne","family":"Moodie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thu T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Pinlac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa W. M.","family":"Saweirs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve Z.","family":"Steiner-Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwen","family":"TeWhare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Tomlins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Upjohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael C.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,14]]},"reference":[{"key":"7715_CR1","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.","journal-title":"BMJ"},{"issue":"3","key":"7715_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137.","journal-title":"Ann Intern Med"},{"key":"7715_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2147\/IJNRD.S123618","volume":"11","author":"WL Salzer","year":"2018","unstructured":"Salzer WL. Peritoneal dialysis-related peritonitis: challenges and solutions. Int J Nephrol Renovasc Dis. 2018;11:173\u201386.","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"11","key":"7715_CR4","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1681\/ASN.2016010112","volume":"27","author":"R Mehrotra","year":"2016","unstructured":"Mehrotra R, Devuyst O, Davies SJ, Johnson DW. The current state of peritoneal dialysis. J Am Soc Nephrol. 2016;27(11):3238\u201352.","journal-title":"J Am Soc Nephrol"},{"issue":"33","key":"7715_CR5","first-page":"18","volume":"2017","author":"A Ueda","year":"2017","unstructured":"Ueda A, Nagai K, Hirayama A, Saito C, Yamagata K. Peritoneal dialysis preserves residual renal function and reduces oxidative stress during the initial period of dialysis therapy. Adv Perit Dial. 2017;2017(33):18\u201321.","journal-title":"Adv Perit Dial"},{"issue":"1","key":"7715_CR6","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.1038\/s41598-019-42508-z","volume":"9","author":"SW Lee","year":"2019","unstructured":"Lee SW, Lee NR, Son SK, Kim J, Sul AR, Kim Y, et al. Comparative study of peritoneal dialysis versus hemodialysis on the clinical outcomes in Korea: a population-based approach. Sci Rep. 2019;9(1):5905.","journal-title":"Sci Rep"},{"issue":"4","key":"7715_CR7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3747\/pdi.2013.00204","volume":"35","author":"FX Liu","year":"2015","unstructured":"Liu FX, Gao X, Inglese G, Chuengsaman P, Pecoits-Filho R, Yu A. A global overview of the impact of peritoneal dialysis first or favored policies: an opinion. Perit Dial Int. 2015;35(4):406\u201320.","journal-title":"Perit Dial Int"},{"issue":"1","key":"7715_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12882-017-0588-4","volume":"18","author":"H Ye","year":"2017","unstructured":"Ye H, Zhou Q, Fan L, Guo Q, Mao H, Huang F, et al. The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients. BMC Nephrol. 2017;18(1):186.","journal-title":"BMC Nephrol"},{"issue":"5","key":"7715_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/nep.14024","volume":"27","author":"IG Okpechi","year":"2022","unstructured":"Okpechi IG, Jha V, Cho Y, Ye F, Ijezie CI, Jindal K, et al. The case for increased peritoneal dialysis utilization in low- and lower-middle-income countries. Nephrology (Carlton). 2022;27(5):391\u2013403.","journal-title":"Nephrology (Carlton)"},{"issue":"11","key":"7715_CR10","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1001\/jamainternmed.2019.3155","volume":"179","author":"LV Pravoverov","year":"2019","unstructured":"Pravoverov LV, Zheng S, Parikh R, Tan TC, Bhalla N, Reddy C, et al. Trends associated with large-scale expansion of peritoneal dialysis within an integrated care delivery model. JAMA Intern Med. 2019;179(11):1537\u201342.","journal-title":"JAMA Intern Med"},{"issue":"4\u20135","key":"7715_CR11","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1159\/000512839","volume":"50","author":"SM Maierean","year":"2021","unstructured":"Maierean SM, Oliver MJ. Health outcomes and cost considerations of assisted peritoneal dialysis: a narrative review. Blood Purif. 2021;50(4\u20135):662\u20136.","journal-title":"Blood Purif"},{"issue":"5","key":"7715_CR12","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/ckj\/sfz011","volume":"12","author":"A Kramer","year":"2019","unstructured":"Kramer A, Pippias M, Noordzij M, Stel VS, Andrusev AM, Aparicio-Madre MI, et al. The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: a summary. Clin Kidney J. 2019;12(5):702\u201320.","journal-title":"Clin Kidney J"},{"key":"7715_CR13","first-page":"25","volume-title":"45th Report, Chapter 5: Peritoneal dialysis","author":"A Registry","year":"2022","unstructured":"Registry A. 45th Report, Chapter 5: Peritoneal dialysis. Adelaide, Australia: Australia and New Zealand Dialysis and Transplant Registry; 2022. p. 25."},{"issue":"6","key":"7715_CR14","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3747\/pdi.2017.00022","volume":"37","author":"KE Manera","year":"2017","unstructured":"Manera KE, Tong A, Craig JC, Brown EA, Brunier G, Dong J, et al. Standardized Outcomes in Nephrology-Peritoneal Dialysis (SONG-PD): study protocol for establishing a core outcome set in PD. Perit Dial Int. 2017;37(6):639\u201347.","journal-title":"Perit Dial Int"},{"issue":"8","key":"7715_CR15","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1681\/ASN.2011121135","volume":"23","author":"N Boudville","year":"2012","unstructured":"Boudville N, Kemp A, Clayton P, Lim W, Badve SV, Hawley CM, et al. Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J Am Soc Nephrol. 2012;23(8):1398\u2013405.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"7715_CR16","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3747\/pdi.2010.00131","volume":"31","author":"JR Ghali","year":"2011","unstructured":"Ghali JR, Bannister KM, Brown FG, Rosman JB, Wiggins KJ, Johnson DW, et al. Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int. 2011;31(6):651\u201362.","journal-title":"Perit Dial Int"},{"issue":"6","key":"7715_CR17","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3747\/pdi.2011.00057","volume":"31","author":"B Piraino","year":"2011","unstructured":"Piraino B, Bernardini J, Brown E, Figueiredo A, Johnson DW, Lye WC, et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int. 2011;31(6):614\u201330.","journal-title":"Perit Dial Int"},{"issue":"3","key":"7715_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/089686080902900314","volume":"29","author":"A Davenport","year":"2009","unstructured":"Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002\u20132003. Perit Dial Int. 2009;29(3):297\u2013302.","journal-title":"Perit Dial Int"},{"issue":"6","key":"7715_CR19","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1093\/ndt\/gfx051","volume":"32","author":"C Bechade","year":"2017","unstructured":"Bechade C, Guillouet S, Verger C, Ficheux M, Lanot A, Lobbedez T. Centre characteristics associated with the risk of peritonitis in peritoneal dialysis: a hierarchical modelling approach based on the data of the French Language Peritoneal Dialysis Registry. Nephrol Dial Transplant. 2017;32(6):1018\u201323.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"7715_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3747\/pdi.2015.00146","volume":"36","author":"AC Nadeau-Fredette","year":"2016","unstructured":"Nadeau-Fredette AC, Johnson DW, Hawley CM, Pascoe EM, Cho Y, Clayton PA, et al. Center-specific factors associated with peritonitis risk-a multi-center registry analysis. Perit Dial Int. 2016;36(5):509\u201318.","journal-title":"Perit Dial Int"},{"issue":"5","key":"7715_CR21","doi-asserted-by":"publisher","first-page":"611","DOI":"10.21614\/chirurgia.113.5.611","volume":"113","author":"O Mihalache","year":"2018","unstructured":"Mihalache O, Doran H, Mustatea P, Bobirca F, Georgescu D, Birligea A, et al. Surgical complications of peritoneal dialysis. Chirurgia (Bucur). 2018;113(5):611\u201324.","journal-title":"Chirurgia (Bucur)"},{"issue":"3","key":"7715_CR22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/nep.12992","volume":"23","author":"N Boudville","year":"2018","unstructured":"Boudville N, Cho Y, Equinox KL, Figueiredo AE, Hawley CM, Howard K, et al. Teaching peritoneal dialysis in Australia: an opportunity for improvement. Nephrology (Carlton). 2018;23(3):259\u201363.","journal-title":"Nephrology (Carlton)"},{"issue":"1","key":"7715_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1053\/j.ajkd.2018.12.033","volume":"74","author":"V Briggs","year":"2019","unstructured":"Briggs V, Davies S, Wilkie M. International variations in peritoneal dialysis utilization and implications for practice. Am J Kidney Dis. 2019;74(1):101\u201310.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"7715_CR24","first-page":"214","volume":"31","author":"L Zhang","year":"2016","unstructured":"Zhang L, Hawley CM, Johnson DW. Focus on peritoneal dialysis training: working to decrease peritonitis rates. Nephrol Dial Transplant. 2016;31(2):214\u201322.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"7715_CR25","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.kint.2022.07.006","volume":"102","author":"DM Reidlinger","year":"2022","unstructured":"Reidlinger DM, Johnson DW, Craig JC, McDonald SP, Mallard AR, Robison LE, et al. Implementation strategies for high impact nephrology trials: the end of the trial is just the beginning. Kidney Int. 2022;102(6):1222\u20137.","journal-title":"Kidney Int"},{"issue":"6","key":"7715_CR26","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3747\/pdi.2015.00277","volume":"36","author":"AE Figueiredo","year":"2016","unstructured":"Figueiredo AE, Bernardini J, Bowes E, Hiramatsu M, Price V, Su C, et al. A syllabus for teaching peritoneal dialysis to patients and caregivers. Perit Dial Int. 2016;36(6):592\u2013605.","journal-title":"Perit Dial Int"},{"issue":"2","key":"7715_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3747\/pdi.2016.00120","volume":"37","author":"CC Szeto","year":"2017","unstructured":"Szeto CC, Li PK, Johnson DW, Bernardini J, Dong J, Figueiredo AE, et al. ISPD catheter-related infection recommendations: 2017 update. Perit Dial Int. 2017;37(2):141\u201354.","journal-title":"Perit Dial Int"},{"issue":"2","key":"7715_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/08968608221080586","volume":"42","author":"PK Li","year":"2022","unstructured":"Li PK, Chow KM, Cho Y, Fan S, Figueiredo AE, Harris T, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022;42(2):110\u201353.","journal-title":"Perit Dial Int"},{"issue":"2","key":"7715_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3747\/pdi.2018.00159","volume":"39","author":"JSF Chow","year":"2019","unstructured":"Chow JSF, Cho Y, Equinox KL, Figueiredo A, Frasca S, Hawley C, et al. An intervention design: supporting skills development for peritoneal dialysis trainers. Perit Dial Int. 2019;39(2):134\u201341.","journal-title":"Perit Dial Int"},{"issue":"2","key":"7715_CR30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1177\/0896860819887283","volume":"40","author":"JS Chow","year":"2020","unstructured":"Chow JS, Adams K, Cho Y, Choi P, Equinox KL, Figueiredo AE, et al. Targeted Education ApproaCH to improve Peritoneal Dialysis Outcomes (TEACH-PD): a feasibility study. Perit Dial Int. 2020;40(2):153\u201363.","journal-title":"Perit Dial Int"},{"issue":"5","key":"7715_CR31","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3747\/pdi.2019.00021","volume":"39","author":"MAL Maley","year":"2019","unstructured":"Maley MAL, Patel RS, Lafferty NT, Steiner GZ, Chow JSF, Johnson DW, et al. A theory-driven, evidence-based approach to implementing the ISPD syllabus-patients as learners. Perit Dial Int. 2019;39(5):409\u201313.","journal-title":"Perit Dial Int"},{"issue":"1","key":"7715_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1473-3099(13)70258-5","volume":"14","author":"DW Johnson","year":"2014","unstructured":"Johnson DW, Badve SV, Pascoe EM, Beller E, Cass A, Clark C, et al. Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial. Lancet Infect Dis. 2014;14(1):23\u201330.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"7715_CR33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"1","key":"7715_CR34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12955-016-0537-0","volume":"14","author":"N McCaffrey","year":"2016","unstructured":"McCaffrey N, Kaambwa B, Currow DC, Ratcliffe J. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms. Health Qual Life Outcomes. 2016;14(1):133.","journal-title":"Health Qual Life Outcomes"},{"key":"7715_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95: 103208.","journal-title":"J Biomed Inform"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07715-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07715-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07715-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T17:02:39Z","timestamp":1699981359000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07715-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,14]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7715"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07715-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2999988\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,14]]},"assertion":[{"value":"30 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for this study has been granted by the South Western Sydney Local Health District Human Research Ethics Committee (AU\/1\/970A317) in Australia (see Additional file\n                      \n                      ) and the Northern B Health and Disability Ethics Committee (19\/NTB\/133) in New Zealand (See Additional file\n                      \n                      ). We confirm that all methods were performed in accordance with the relevant guidelines and regulations. This study did not include the use of tissue samples. All informed consent forms have been approved by a responsible Independent Ethics Committee with jurisdiction for the participating site prior to the beginning of the trial at each site. All eligible participants will be presented with the participant information sheet and consent form outlining the purpose and content of the survey. Written informed consent will be obtained from all participants prior to the commencement of the research activities. They will be informed that they can withdraw from the study at any time.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable. The study does not require consent for publication from participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"Josephine S F Chow has previously received speaker\u2019s honoraria and research funds from Baxter Healthcare, Fresenius Medical Care, Roche Pharmaceuticals and Amgen. Neil Boudville has Otsuka honorarium. Advisory board member for Astra Zeneca Advisory Board, GSK Advisory Board and Vifor Advisory Board. Received consultancy fees from Baxter Healthcare. Yeoungjee Cho has Speaker\u2019s honoraria and research grants from Baxter Healthcare and Fresenius Medical Care. Walaa W M Saweirs has Speaker\u2019s honoraria from Baxter. Rachael C Walker has previously received speaker\u2019s honoraria and research funds from Baxter Healthcare. David W Johnson has previously received consultancy fees, research grants, speaker\u2019s honoraria, and travel sponsorships from Baxter Healthcare and Fresenius Healthcare. Megan Upjohn attended Baxter Education Days in last few years. Rathika Krishnasamy received grants and speaking honoraria from Baxter International. Received consultancy fees from Astra Zeneca. Kamal Sud has speaker\u2019s honoraria from Baxter Healthcare and Medical Advisory Board member for Australia and New Zealand of Fresenius Medical Care. David C Wheeler has competing interests with Astellas, AstraZeneca, Boehringer Ingelheim, Eledon, GlaxoSmithKline, Galderma, Gilead, Janssen, ProKidney, Tricida, Vifor, and Zydus. Paula Woodward received financial support from The Home Network for development of training modules used during the TEACH-PD trial.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"730"}}